As of February 2026 Adaptimmune Therapeutics has a market cap of A$20.55 Million. This makes Adaptimmune Therapeutics the world's 10225th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.